Skip to main content
Minnesota Department of Health logo
  • Main navigation

    • Home
    • Data, Statistics, and Legislation
    • Diseases and Conditions
    • Health Care Facilities, Providers, and Insurance
    • Healthy Communities, Environment, and Workplaces
    • Individual and Family Health
    • About Us
    • News and Announcements
    • Translated Materials

Main navigation mobile

  • Data, Statistics, and Legislation
  • Diseases and Conditions
  • Health Care Facilities, Providers, and Insurance
  • Healthy Communities, Environment, and Workplaces
  • Individual and Family Health
  • About Us
  • News and Announcements
  • Translated Materials
MDH Logo

Breadcrumb

  1. Home
  2. Diseases and Conditions
  3. Influenza (Flu)
  4. Novel and Variant Influenza A Viruses
Topic Menu

Novel and Variant Influenza A Viruses

  • Novel and Variant Flu Home
  • Novel Influenza A
    • Current HPAI H5N1 Avian Influenza Outbreak
    • Novel Flu (including HPAI H5N1) for Health Professionals
  • Variant Influenza A
    • Variant Flu For Exhibition Managers
    • Variant Flu For Health Professionals

Related Topics

  • Where to Get Vaccinated
  • Flu Home

Novel and Variant Influenza A Viruses

  • Novel and Variant Flu Home
  • Novel Influenza A
    • Current HPAI H5N1 Avian Influenza Outbreak
    • Novel Flu (including HPAI H5N1) for Health Professionals
  • Variant Influenza A
    • Variant Flu For Exhibition Managers
    • Variant Flu For Health Professionals

Related Topics

  • Where to Get Vaccinated
  • Flu Home
Contact Info
Infectious Disease Epidemiology, Prevention and Control Division
651-201-5414
IDEPC Comment Form

Contact Info

Infectious Disease Epidemiology, Prevention and Control Division
651-201-5414
IDEPC Comment Form

Information for Health Professionals on Influenza A Variant Viruses (H3N2v, H1N2v, H1N1v)

Specimen collection and testing

  • Commercially available rapid influenza diagnostic tests may not detect H3N2v, H1N2v, or H1N1v in respiratory specimens.
  • MDH is very interested in conducting RT-PCR testing for surveillance purposes on outpatients with illness compatible with influenza* who meet any of the following criteria:
    • Recent (7 days or less) direct or in-direct contact with swine.
    • Recent attendance at an agricultural fair where swine were present.
    • Recent contact with a confirmed case of variant or swine influenza A infection (such as H3N2v, H1N2v, or H1N1v).

* Illness compatible with influenza may present as influenza-like illness (ILI):
fever ≥100°F plus cough and sore throat.
Note that influenza may not cause fever in all patients (especially in patients < 5 years of age, ≥ 65 years of age, or patients with suppression of their immune system).

For patients admitted with ILI or clinical suspicion of influenza without evidence of pneumonia or other lower respiratory disease – submit one upper respiratory specimen per patient.

  • Nasopharyngeal swab is the preferred specimen
  • Other acceptable specimens include nasal swab, nasal wash/aspirate, throat swab, or combined nasal swab with an oropharyngeal swab, and viral culture

  • Place respiratory specimens into viral transport media (VTM; e.g., M4, M5, Universal Transport Media) for transport to MDH-PHL. Washes and aspirates may be collected in saline and placed into 1-3 milliliters viral transport media.
    • Store and ship at refrigeration temperature.
    • Freeze specimen, and ship frozen, if it will not reach MDH-PHL within 7 days.
  • Swabs collected and/or transported in non-sterile containers, baggies, or without transport media (dry) will not be accepted.
  • Ship at refrigeration temperature.
  • New England Journal of Medicine: H1N1 Influenza A Disease - Information for Health Professionals
    Refer to Collection of Nasopharyngeal Specimens with the Swab Technique video.

Please indicate "swine exposure" as appropriate.

Only a single Clinical Testing and Submission Form is required; however, you must use the correct version of the form, which is dependent on whether the patient is hospitalized or not.
NOTE: There is NO fee sticker required for influenza testing.

Non-Hospitalized Influenza Testing (Project #493)
Use this form for submitting specimens for influenza testing from non-hospitalized patients. Write project #493 in the upper right-hand corner of the form and indicate "swine exposure" as appropriate.

  • Infectious Disease Laboratory Submission Form (PDF)
    Printable and/or fillable. More information can be found on Forms for the Infectious Disease Laboratory

Hospitalized Patients Only (Project #1492)
Use this form for all specimens submitted from persons hospitalized with ILI or clinical suspicion of influenza. In order to allow for prompt testing of submitted specimens for project #1492, please be sure to fill out the form completely, especially information regarding hospitalization (date of admission, hospital of admission, and outcome) found on the lower right-hand corner of the form, and indicate "swine exposure" as appropriate.

  • Hospitalized Influenza Submission Form Project 1492 (PDF)
    • Influenza Form Guidance (PDF)
      More information can be found on Forms for the Infectious Disease Laboratory

Shipping to MDH-PHL

  • Ship at refrigeration temperature.
    • Use cold packs to keep specimens at 4 degrees C.
  • Ship specimens to MDH-PHL by an overnight delivery service.
    • NOTE: It is the responsibility of the submitting laboratory to determine the appropriate packaging and shipping for patient specimens and culture isolates.
    • DOT HAZMAT regulations: PHMSA Regulations
  • Ship to:
    Minnesota Department of Health
    Public Health Laboratory
    Attn: Biological Accessioning
    601 Robert St. N
    St. Paul, Minnesota 55155-2531

Questions?

  • For an MDH epidemiologist, call 651-201-5414 or 1-877-676-5414.
  • During business hours you can call the Virology Supervisor at 651-201-5035.

Commercially available rapid influenza diagnostic tests may not detect H3N2v, H1N2v, or H1N1v in respiratory specimens.

  • CDC: Evaluation of Rapid Influenza Diagnostic Tests for Influenza A (H3N2)v Virus Infections and Updated Case Count – United States, 2012 (PDF). CDC Morbidity and Mortality Weekly Report 2012. Early Release August 10, 2012.

Surveillance and reporting

  • Reporting Influenza
    In Minnesota, influenza is a reportable disease.
  • MDH is also conducting enhanced surveillance through established sentinel influenza surveillance sites.

More about seasonal and novel influenza A for Health professionals:

  • Influenza Information for Health Professionals
  • Information For Health Professionals on Novel Influenza A Viruses

Treatment

  • Clinicians should consider antiviral treatment with oral oseltamivir or inhaled zanamivir in patients with suspected or confirmed variant or swine influenza virus infection.
  • Antiviral treatment is most effective when started as soon as possible after influenza illness onset.
  • Testing at the Minnesota Department of Health may take several days and the decision to treat should be based on clinical judgment.

Further information on diagnosis and treatment

CDC: Variant Influenza Information for Health Professionals and Laboratorians
Case definitions, infection control, guidance, and other resources.

Tags
  • flu
Last Updated: 12/10/2024

Get email updates


Minnesota Department of Health logo

Privacy Policy
Equal Opportunity
Translated Materials
Feedback Form
About MDH
Minnesota.gov
  • Facebook
  • Twitter
  • Linked In
  • Instagram
  • Youtube
Minnesota Department of Health Minnesota Department of health print search share facebook instagram linkedin twitter youtube